Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 1323
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT00130702 | Study of Iressa in Patients With Relapsed or Refractory Acute Myelogenous Leukemia | ||
| NCT00317603 | Vaccination With Autologous Breast Cancer Cells Engineered to Secrete Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in Metastatic Breast Cancer Patients | ||
| NCT01773395 | GVAX vs. Placebo for MDS/AML After Allo HSCT | ||
| NCT03070145 | Exercise Intervention Among Men With Prostate Cancer Initiating Androgen Deprivation Therapy | ||
| NCT03835819 | A Phase 2 Study of Mirvetuximab Soravtansine (IMGN853) and Pembrolizumab in Endometrial Cancer (EC) | ||
| NCT00137800 | Study of OSI-774 (Tarceva) in Previously Untreated Elderly Lung Cancer Patients | ||
| NCT01222572 | Stereotactic Boost for Locally Advanced Non-Small Cell Lung Cancer | ||
| NCT00264602 | Real-Time Image Guided Lymphatic Mapping and Nodal Targeting in Lung Cancer | ||
| NCT00006127 | Phase I Study of Amifostine in Patients With Bone Marrow Failure Related to Fanconi's Anemia | ||
| NCT06328127 | Positive Psychology Intervention for Hematopoietic Stem Cell Transplantation Survivors | ||
| NCT00116142 | Hormone Suppression and Radiation Therapy for 6 Months With/Without Docetaxel for High Risk Prostate Cancer | ||
| NCT04541654 | Li-Fraumeni & TP53 (LiFT UP): Understanding and Progress | ||
| NCT02919969 | Pembrolizumab in Metastatic Anal Cancer | ||
| NCT03137537 | Ivabradine in the Management of Cardiac Autonomic Dysfunction Associated With Thoracic Radiation Therapy. | ||
| NCT00345540 | Efficacy of NOV-002 in Combination With Carboplatin in Chemotherapy-resistant Ovarian Cancer | ||
| NCT02867384 | Obinutuzumab in cGVHD After Allogeneic Peripheral Blood Stem Cell Transplantation | ||
| NCT01250717 | Docetaxel Followed by Radical Prostatectomy in Patients With High Risk Localized Prostate Cancer | ||
| NCT04708860 | Feasibility of Fasting & Exercise in Pts With HR+ MBC | ||
| NCT02648997 | An Open-Label Phase II Study of Nivolumab or Nivolumab/Ipilimumab in Adult Participants With Progessive/ Recurrent Meningioma | ||
| NCT04094961 | Ixazomib + Pomalidomide + Dexamethasone In MM | ||
| NCT07624513 | D2 - Isa-Iber-VD Induction, Followed by Risk & Response Adapted Consolidation & Maintenance, in Transplant-Eligible NDMM | ||
| NCT00165282 | Mindfulness Meditation in Bone Marrow Transplantation | ||
| NCT01208662 | Randomized Trial of Lenalidomide, Bortezomib, Dexamethasone vs High-Dose Treatment With SCT in MM Patients up to Age 65 | ||
| NCT06945120 | ACT Lung Health Intervention: Phase Two | ||
| NCT00321646 | Neoadjuvant Bevacizumab Plus Docetaxel in High Risk Patients With Prostate Cancer Undergoing Radical Prostatectomy | ||
| NCT01959542 | Early Changes In Multiparametric MRI In Prostate Cancer | ||
| NCT06038318 | Promoting Resilience in Early Survivorship Among Adolescents and Young Adults With Cancer | ||
| NCT00470847 | Lapatinib in Combination With Radiation Therapy in Patients With Brain Metastases From HER2-Positive Breast Cancer | ||
| NCT02251548 | A Phase II Study of Ibrutinib Plus FCR in Previously Untreated, Younger Patients With Chronic Lymphocytic Leukemia | ||
| NCT07774104 | A Structured Peer Support Intervention for Patients Undergoing Hematopoietic Stem Cell Transplantation | ||
| NCT02410252 | Use Feasibility of the iThermonitor in Pediatrics Patients on Myelosuppresive Therapies | ||
| NCT01290263 | Amgen 386 for Recurrent Glioblastoma | ||
| NCT06722014 | Integrating Pain-CBT Into an mHealth Analgesic Support Intervention for Patients With Chronic Pain From Advanced Cancers | ||
| NCT00458536 | Vaccination of Patients With Renal Cell Cancer With Dendritic Cell Tumor Fusions and GM-CSF | ||
| NCT04166487 | Plasma-Adapted First-Line Pembro In NSCLC | ||
| NCT02390414 | The Myelodysplasia Transplantation-Associated Outcomes (MDS-TAO) Study | ||
| NCT06710548 | REVITALIZE: RCT to Reduce Fatigue in Adults With Ovarian Cancer on PARP Inhibitors | ||
| NCT03602885 | EL CENTRO: Engaging Latinos in the Center of Cancer Treatment Options | ||
| NCT03277469 | Optimizing Brachytherapy Application and Delivery With MRI Guidance for Gynecologic Cancer | ||
| NCT00476086 | Oxaliplatin and Gemcitabine Followed by Radiation Therapy in the Management of Mixed Mullerian Tumors of the Uterus | ||
| NCT00438854 | Dasatinib in Relapsed Chronic Lymphocytic Leukemia | ||
| NCT03436654 | Multi-arm Multi-modality Therapy for Very High Risk Localized and Low Volume Metastatic Prostatic Adenocarcinoma | ||
| NCT00487305 | Vaccination for the Treatment of Previously Untreated or Relapsed Follicular Lymphoma | ||
| NCT04525183 | REVITALIZE: A Telehealth Intervention for Women With Advanced Ovarian Cancer and PARP Inhibitor-Related Fatigue | ||
| NCT07052695 | Mosunetuzumab for CLL MRD Clearance | ||
| NCT03717480 | Ex Vivo TCR αβ T Cell Depletion for Graft-Versus-Host Disease Prophylaxis in Mismatched Donor Peripheral Blood Stem Cell Transplantation for Hematologic Malignancies | ||
| NCT01961128 | RPFNA Assessment of Exercise Effect in Breast Cancer | ||
| NCT01958112 | GSK1120212+GSK2141795 for Cervical Cancer | ||
| NCT04305145 | Infliximab for Treatment of Immune Checkpoint Inhibitor Colitis | ||
| NCT03236428 | Phase II Study of the CD38 Antibody Daratumumab in Patients With High-Risk MGUS and Low-Risk Smoldering Multiple Myeloma |
